Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

Summary

The purpose of this study is to investigate the efficacy and safety of a topical gel formulation of nitroglycerin, in comparison to a matching placebo, for patients with moderate to severe primary Raynaud's phenomenon or patients with Raynaud's phenomenon secondary to autoimmune diseases, such as scleroderma.

Timeline

Start

2005-12

Primary completion

—

Completion

2006-05

Drugs

Indications